Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Emphysema

Explore clinical trials studying Pulmonary Emphysema. Study availability and eligibility vary by location and protocol.

45 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Emphysema trial results

Completed

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency

NCT00460096

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida School of Medicine Gainesville, Florida, United States
  • The University of Texas Health Center at Tyler Tyler, Texas, United States
View Trial Details
Active, Not Recruiting

Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)

NCT01983241

Conditions
Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +14 more
Locations
  • Grifols Investigative Site Phoenix, Arizona, United States
  • Grifols Investigative Site Gainesville, Florida, United States
  • Grifols Investigative Site Leesburg, Florida, United States
  • Grifols Investigative Site Miami, Florida, United States
View all 52 locations
View Trial Details

Related conditions